Open AccessArthropod-Derived Histamine-Binding Protein Prevents Murine Allergic Asthma
Author(s) -
Isabelle Couillin,
Isabelle Maillet,
B. Boris Vargaftig,
Muazzam Jacobs,
Guido C. Paesen,
Adriana Patrícia,
Jean Lefort,
René Moser,
Wynne WestonDavies,
Bernhard Ryffel
Publication year - 2004
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.173.5.3281
Subject(s) - histamine , immunology , asthma , medicine , inhibitory postsynaptic potential , antihistamine , blockade , histamine receptor , receptor , allergic inflammation , histamine h1 receptor , eosinophilia , immunoglobulin e , pharmacology , antibody , antagonist
Because histamine receptor type I blockade attenuates allergic asthma, we asked whether complete neutralization of histamine by an arthropod-derived, high affinity histamine-binding protein (EV131) would prevent allergic asthma. Intranasal administration of EV131 given before Ag challenge in immunized mice prevented airway hyperreactivity by 70%, and abrogated peribronchial inflammation, pulmonary eosinophilia, mucus hypersecretion, and IL-4 and IL-5 secretion. Saturation with histamine abrogated the inhibitory effect of EV131 on bronchial hyperreactivity. The inhibitory effect of EV131 on bronchial hyperreactivity was comparable to that of glucocorticosteroids. These results demonstrate that histamine is a critical mediator of allergic asthma. Therefore, complete neutralization of histamine, rather than specific histamine receptor blockade, may have a profound effect on allergic asthma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom